查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2057525

2035年全球癌症腫瘤分析市場報告

Cancer Tumor Profiling Global Market Opportunities And Strategies To 2035
出版日期: | 出版商: The Business Research Company | 英文 430 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

2020 年全球癌症腫瘤分析市場價值 80.935 億美元，預計到 2025 年將以超過 13.00% 的複合年成長率成長。

腫瘤譜分析是指對癌組織進行全面的分子和遺傳分析，以識別特定的突變、基因表現、蛋白質標記、表觀遺傳修飾和其他腫瘤相關的生物學特徵。這有助於闡明癌症的分子結構，並指導腫瘤學領域的臨床和研究決策。

癌症腫瘤譜分析市場包括為腫瘤內科醫生、病理學家、分子生物學家、學術研究人員、製藥和生物技術公司以及受託研究機構(夥伴關係) 提供癌症腫瘤譜分析服務的服務提供者（包括機構、自僱者和合夥企業）的收入。此技術應用於腫瘤亞型的初步診斷、治療方法選擇時的治療標靶識別、治療期間的治療反應和抗藥性監測，以及復發時腫瘤進展的重新評估。

全球癌症發生率不斷上升

從歷史上看，癌症腫瘤譜分析市場的發展主要受全球癌症發生率上升的驅動。癌症是一種異常細胞不受控制地生長和擴散的疾病，癌細胞會侵入周圍組織，並可能轉移到身體其他部位。導致癌症發生率上升的主要因素之一是人口老化，因為基因突變和細胞損傷的可能性會隨著老齡化的成長而增加。隨著全球平均預期壽命的延長，越來越多的人進入高風險年齡層，導致癌症患者人數的增加。癌症腫瘤譜分析透過分析腫瘤的​​分子和遺傳特徵來支持癌症管理，加深我們對腫瘤行為的理解，從而為更明智的臨床決策提供基礎。例如，根據世界衛生組織（WHO，聯合國負責協調應對國際公共衛生問題和突發事件的專門機構）的數據，截至2024年2月，2022年估計新增癌症病例2000萬例，死亡970萬人。估計有5350萬人在確診癌症後的五年內仍然存活。大約五分之一的人一生中會罹患癌症，約九分之一的男性和十二分之一的女性會死於癌症。此外，預計到2024年，美國新增癌症病例將超過200萬例。因此，全球癌症發生率的上升是近年來癌症腫瘤分析市場發展的主要驅動力。

生物技術、基因組學和精準醫療

癌症腫瘤譜分析市場的領導者正日益關注生物技術、基因組學和精準醫學，以提高分子診斷的準確性、深度和臨床意義。透過整合先進的定序技術、多組體學平台和人工智慧分析，他們旨在提供腫瘤生物學和可操作基因突變的全面見解。生物技術、基因組學和精準醫學在推進癌症腫瘤譜分析方面發揮著至關重要的作用，它們能夠從DNA、 體學和蛋白質水平對腫瘤進行詳細的分子表徵。先進的定序技術，例如次世代定序和多組學平台，能夠識別促進癌症進展的基因突變、生物標記和訊號通路異常。在精準醫學的框架下，這些見解可用於指導標靶治療的選擇、最佳化治療反應並最大限度地減少不必要的干涉。生物技術的創新正在進一步推動高靈敏度檢測方法的發展，包括液態生物檢體和伴隨診斷，從而增強早期檢測和疾病監測。這些進步共同改變了癌症腫瘤分析的格局，從傳統的組織病理學分析轉向數據驅動的個人化腫瘤解決方案，從而改善臨床決策和患者預後。

全球癌症腫瘤分析市場較為分散，許多小規模企業在其中營運。截至2024年，排名前十的主要企業僅佔市場總額的14.070%。

目錄

第1章：執行摘要

第2章 目錄

第3章表格一覽

第4章：圖表一覽

第5章：報告結構

第6章 市場特徵

  • 市場的一般定義
  • 概述
  • 癌症腫瘤分析市場：定義與細分
  • 癌症類型市場細分（肺癌、乳癌、大腸癌、攝護腺癌、惡性黑色素瘤、卵巢癌、胃癌、胰臟癌、甲狀腺癌及其他癌症類型）
  • 按技術分類的市場細分（次世代定序(NGS)、聚合酵素鏈鎖反應(PCR)、免疫組織化學 (IHC)、原位雜合反應(ISH)、微陣列和其他技術）
  • 按流程分類的市場細分（基因體學、蛋白質體學、表觀遺傳學等）
  • 按應用領域分類的市場細分（個人化醫療、診斷、生物標記發現、預後預測和研究應用）

第7章：癌症腫瘤分析市場主要產品與服務概述

  • 全球癌症腫瘤特徵分析市場：吸引力評分及分析
    • 市場吸引力框架概述
    • 定量評分調查方法
    • 市場吸引力評分的計算與解讀
    • 因素特定評估
    • 戰略洞察與建議

第8章：主要市場趨勢

  • 關鍵科技與未來趨勢
    • 生物技術、基因組學和精準醫療
    • 人工智慧和自主智慧
    • 數位化、雲端運算、巨量資料和網路安全
    • 工業4.0和智慧製造
    • 物聯網 (IoT)、智慧基礎設施和互聯生態系統
  • 主要趨勢
    • 用於全面基因組分析的液態生物檢體多基因檢測
    • 基於雜交捕獲技術的綜合腫瘤定序平台的出現。
    • 用於精準腫瘤學的先進多基因癌症譜分析解決方案
    • 基於全EXOME顯子定序的腫瘤譜分析檢測的出現。

第9章 全球癌症腫瘤特徵分析：成長分析與策略分析框架

  • 全球癌症腫瘤譜分析市場：PESTEL 分析
  • 最終用戶（B2B）分析
    • 醫院及癌症治療中心
    • 診斷檢查室和病理檢查室
    • 製藥和生物製藥公司
    • 學術研究機構
    • 受託研究機構（CRO）
  • 全球癌症腫瘤分析市場：規模與成長分析
  • 2020-2025年市場成長表現
    • 市場促進因素，2020-2025 年
    • 2020-2025年市場限制因素
  • 市場成長預測，2025-2030年，2035年
  • 預測成長要素和促進因素
    • 定量成長要素
    • 促進因素
    • 抑制因子

第10章：全球癌症腫瘤分析市場規模（TAM）分析

  • 總潛在市場（TAM）的定義與範圍
  • 調查方法和先決條件
    • 可觸及市場總量：癌症腫瘤分析市場 - B2C
    • TAM比較分析

第11章 全球癌症腫瘤譜分析：市場區隔

  • 按癌症類型
  • 透過技術
  • 透過流程
  • 透過使用
  • 細分（按類型）：肺癌
  • 按類型細分：乳癌
  • 按類型細分：大腸直腸癌
  • 細分（按類型）：前列腺癌
  • 按類型細分：黑色素瘤
  • 按類型細分：卵巢癌
  • 亞分類（按類型）：胃癌
  • 亞分類（按類型）：胰腺癌
  • 亞分類（按類型）：甲狀腺癌
  • 細分（按類型）：其他癌症類型

第12章 癌症腫瘤分析市場：區域與國家分析

第13章 亞太市場

第14章 東南亞市場

第15章 西歐市場

第16章：東歐市場

第17章：北美市場

第18章：南美洲市場

第19章 中東市場

第20章：非洲市場

第21章：競爭格局與公司概況

  • Cancer Tumor Profiling Market Competitive Landscape And & Market Share 2024
  • 公司簡介
  • Illumina Inc（Company Overview, Products and Services, Business Strategy, Financial Overview）
  • Thermo Fisher Scientific Inc（Company Overview, Products and Services, Business Strategy, Financial Overview）
  • F. Hoffmann-La Roche Ltd.（Foundation Medicine）（Company Overview, Products and Services, Business Strategy, Financial Overview）
  • Caris Life Sciences Inc（Company Overview, Products and Services, Business Strategy, Financial Overview）
  • Qiagen NV（Company Overview, Products and Services, Business Strategy, Financial Overview）

第22章 其他大型企業和創新企業

  • Tempus AI Inc.
  • NeoGenomics Laboratories Inc.
  • Exact Sciences Corporation
  • Myriad Genetics Inc.
  • Veracyte Inc.
  • Bio-Rad Laboratories Inc.
  • Sysmex Corporation
  • Guardant Health Inc.
  • Hologic Inc.
  • Invitae Corporation
  • Natera Inc.
  • NantHealth Inc.
  • RareCyte Inc.
  • Personal Genome Diagnostics Inc.
  • Strand Life Sciences Pvt. Ltd.

第23章：競爭標竿分析

第24章：競爭對手儀錶板

第25章：癌症腫瘤分析市場－公司評估矩陣

  • 創新與品牌領導者
  • 新興創新者
  • 品牌主導的傳統主義者
  • 利基市場或區域追隨者

第26章：預計進入市場的新創企業

第27章 重大併購

  • Natera Acquired Foresight Diagnostics
  • Quest Diagnostics Acquired Haystack Oncology

第28章 近期趨勢

  • 旨在實現乳癌治療個人化的「AI Insights Signature」已經發布。
  • 已啟動用於精準腫瘤學的多組體學組織分析檢測。

第29章 機遇與策略

  • 2030年全球癌症腫瘤分析市場：蘊藏新機會的國家
  • 2030年全球癌症腫瘤分析市場：蘊藏新機會的細分市場
  • 2030年全球癌症腫瘤分析市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第30章：癌症腫瘤分析市場：結論與建議

  • 結論
  • 推薦

第31章附錄

簡介目錄
Product Code: HS4MCTPU01_O26Q1

Cancer tumor profiling refers to the comprehensive molecular and genetic analysis of cancerous tissues to identify specific mutations, gene expressions, protein markers, epigenetic modifications and other biological characteristics associated with a tumor. It is used to characterize the molecular architecture of cancer and to guide clinical and research decision-making in oncology.

The cancer tumor profiling market consists of sales by entities (organizations, sole traders and partnerships) of cancer tumor profiling that are used by oncologists, pathologists, molecular biologists, academic researchers, pharmaceutical and biotechnology companies and contract research organizations. It is applied at the time of initial diagnosis to classify tumor subtypes, during treatment selection to identify actionable targets, throughout therapy to monitor response or resistance and at recurrence to reassess tumor evolution.

The global cancer tumor profiling market was valued at $8,093.5 million in 2020 which grew till 2025 at a compound annual growth rate (CAGR) of more than 13.00%.

Rising Global Cancer Incidence

During the historic period, the cancer tumor profiling market was significantly driven by the rising global cancer incidence. Cancer is a disease characterized by the uncontrolled growth and spread of abnormal cells that can invade surrounding tissues and potentially spread to other parts of the body. One key factor contributing to the rising incidence of cancer is the aging population, as the likelihood of genetic mutations and cellular damage increases with age. With longer life expectancy worldwide, more individuals fall into high-risk age groups, leading to a greater number of cancer cases. Cancer tumor profiling supports cancer management by analyzing the molecular and genetic characteristics of tumors, enabling deeper understanding of tumor behavior and guiding more informed clinical decision-making. For example, in February 2024, according to the WHO (World Health Organization), a specialized agency of the United Nations which coordinates responses to international public health issues and emergencies, in 2022, there were an estimated 20 million new cancer cases and 9.7 million deaths. The estimated number of people who were alive within 5 years following a cancer diagnosis was 53.5 million. About 1 in 5 people develop cancer in their lifetime, approximately 1 in 9 men and 1 in 12 women die from the disease. , over 2 million new cancer cases are projected for the U.S. in 2024. Therefore, the cancer tumor profiling market was significantly driven by the rising global cancer incidence during the historic period.

Biotechnology, Genomics And Precision Medicine

Major companies in the cancer tumor profiling market are increasingly prioritizing biotechnology, genomics and precision medicine to enhance the accuracy, depth and clinical relevance of molecular diagnostics. By integrating advanced sequencing technologies, multi-omics platforms and AI-driven analytics, they aim to deliver comprehensive insights into tumor biology and actionable genetic alterations. Biotechnology, genomics and precision medicine play a critical role in advancing cancer tumor profiling by enabling detailed molecular characterization of tumors at the DNA, RNA and protein levels. Advanced sequencing technologies, such as next-generation sequencing and multi-omics platforms, allow for the identification of genetic mutations, biomarkers and pathway alterations that drive cancer progression. Precision medicine frameworks use these insights to guide targeted therapy selection, optimize treatment response and minimize unnecessary interventions. Biotechnology innovations further support the development of high-sensitivity assays, including liquid biopsy and companion diagnostics, enhancing early detection and disease monitoring. Collectively, these advancements are reshaping the cancer tumor profiling landscape by shifting it from conventional histopathological analysis toward data-driven, personalized oncology solutions that improve clinical decision-making and patient outcomes.

The global cancer tumor profiling market is fragmented, with a large number of small players operating in the market. The top 10 competitors in the market made up 14.070% of the total market in 2024.

Cancer Tumor Profiling Global Market Opportunities And Strategies To 2035 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global cancer tumor profiling market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for cancer tumor profiling? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cancer tumor profiling market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider cancer tumor profiling market; and compares it with other markets.

The report covers the following chapters

  • Introduction And Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segments, key products, supply chain and market attractiveness scoring and analysis.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future technologies and developments in the market.
  • Growth Analysis And Strategic Analysis Framework- Analysis on PESTEL, end use industries, market growth rate, global historic (2020-2025) and forecast (2025-2030, 2035F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
  • Regional And Country Analysis- Historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2020-2025) (2025-2030, 2035F) and analysis for each segment by cancer type, by technology, by process type and by application in the market. Historic (2020-2025) and forecast (2025-2030) and (2030-2035) market values and growth and market share comparison by region market.
  • Regional Market Size And Growth- Regional market size (2025), historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies- Details on the startups, company profiles of other major and innovative companies in the market.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers And Acquisitions- Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Recent Developments- Information on recent developments in the market covered in the report.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for cancer tumor profiling providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Cancer Type: Lung Cancer; Breast Cancer; Colorectal Cancer; Prostate Cancer; Melanoma; Ovarian Cancer; Stomach Cancer; Pancreatic Cancer; Thyroid Cancer; Other Cancer Types
  • 2) By Technology: Next-Generation Sequencing (NGS); Polymerase Chain Reaction (PCR); Immunohistochemistry (IHC); In Situ Hybridization (ISH); Microarray; Other Technologies
  • 3) By Process Type: Genomics; Proteomics; Epigenetics; Other Types
  • 4) By Application: Personalized Medicine; Diagnostics; Biomarker Discovery; Prognostics; Research Applications
  • Companies Mentioned: Illumina Inc.; Thermo Fisher Scientific Inc.; F. Hoffmann-La Roche Ltd. (Foundation Medicine); Caris Life Sciences Inc.; QIAGEN N.V.
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; Taiwan; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; cancer tumor profiling indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes."

Table of Contents

1 Executive Summary

  • 1.1 Dashboard

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Cancer Tumor Profiling Market Definition And Segmentations
  • 6.4 Market Segmentation By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Ovarian Cancer, Stomach Cancer, Pancreatic Cancer, Thyroid Cancer And Other Cancer Types)
  • 6.5 Market Segmentation By Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), In Situ Hybridization (ISH), Microarray and Other Technologies)
  • 6.6 Market Segmentation By Process Type (Genomics, Proteomics, Epigenetics And Other Types)
  • 6.7 Market Segmentation By Application (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognostics And Research Applications)

7 Cancer Tumor Profiling Market, Overview Of Key Products/Services

  • 7.1 Global Cancer Tumor Profiling Market Attractiveness Scoring And Analysis
    • 7.1.1 Overview Of Market Attractiveness Framework
    • 7.1.2 Quantitative Scoring Methodology
    • 7.1.3 Market Attractiveness Scoring And Interpretation
    • 7.1.4 Factor-Wise Evaluation
    • 7.1.5 Strategic Implications And Recommendations

8 Major Market Trends

  • 8.1 Key Technologies & Future Trends
    • 8.1.1 Biotechnology, Genomics And Precision Medicine
    • 8.1.2 Artificial Intelligence And Autonomous Intelligence
    • 8.1.3 Digitalization, Cloud, Big Data And Cybersecurity
    • 8.1.4 Industry 4.0 And Intelligent Manufacturing
    • 8.1.5 Internet of Things (IoT), Smart Infrastructure And Connected Ecosystems
  • 8.2 Major Trends
    • 8.2.1 Liquid Biopsy Multi-Gene Panel For Comprehensive Genomic Profiling
    • 8.2.2 Emergence Of Hybrid Capture-Based Comprehensive Oncology Sequencing Platforms
    • 8.2.3 Advanced Multi-Gene Cancer Profiling Solution For Precision Oncology
    • 8.2.4 Emergence Of Whole Exome Sequencing-Based Tumor Profiling Assays

9 Global Cancer Tumor Profiling Growth Analysis And Strategic Analysis Framework

  • 9.1 Global Cancer Tumor Profiling PESTEL Analysis
    • 9.1.1 Political
    • 9.1.2 Economic
    • 9.1.3 Social
    • 9.1.4 Technological
    • 9.1.5 Environmental
    • 9.1.6 Legal
  • 9.2 Analysis Of End User (B2B)
    • 9.2.1 Hospitals And Cancer Treatment Centers
    • 9.2.2 Diagnostic Laboratories And Pathology Labs
    • 9.2.3 Pharmaceutical And Biopharmaceutical Companies
    • 9.2.4 Academic And Research Institutes
    • 9.2.5 Contract Research Organizations (Cros)
  • 9.3 Global Cancer Tumor Profiling Market Size And Growth Analysis
  • 9.4 Historic Market Growth, 2020 - 2025, Value ($ Million)
    • 9.4.1 Market Drivers 2020 - 2025
    • 9.4.2 Market Restraints 2020 - 2025
  • 9.5 Forecast Market Growth, 2025 - 2030, 2035F Value ($ Million)
  • 9.6 Forecast Growth Contributors/Factors
    • 9.6.1 Quantitative Growth Contributors
    • 9.6.2 Drivers
    • 9.6.3 Restraints

10 Global Cancer Tumor Profiling Total Addressable Market (TAM) Analysis

  • 10.1 Definition And Scope of Total Addressable Market (TAM)
  • 10.2 Methodology And Assumptions
    • 10.2.1 Total Addressable Market for the Cancer Tumor Profiling Market - Business to Customer (B2C)
    • 10.2.2 TAM Comparison Analysis

11 Global Cancer Tumor Profiling Market Segmentation

  • 11.1 Global Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 11.2 Global Cancer Tumor Profiling Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 11.3 Global Cancer Tumor Profiling Market, Segmentation By Process Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 11.4 Global Cancer Tumor Profiling Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 11.5 Global Cancer Tumor Profiling Market, Sub Segmentation Of Lung Cancer, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 11.6 Global Cancer Tumor Profiling Market, Sub-Segmentation Of Breast Cancer, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 11.7 Global Cancer Tumor Profiling Market, Sub-Segmentation Of Colorectal Cancer, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 11.8 Global Cancer Tumor Profiling Market, Sub-Segmentation Of Prostate Cancer, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 11.9 Global Cancer Tumor Profiling Market, Sub-Segmentation Of Melanoma, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 11.10 Global Cancer Tumor Profiling Market, Sub-Segmentation Of Ovarian Cancer, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 11.11 Global Cancer Tumor Profiling Market, Sub-Segmentation Of Stomach Cancer, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 11.12 Global Cancer Tumor Profiling Market, Sub-Segmentation Of Pancreatic Cancer, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 11.13 Global Cancer Tumor Profiling Market, Sub-Segmentation Of Thyroid Cancer, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 11.14 Global Cancer Tumor Profiling Market, Sub-Segmentation Of Other Cancer Types, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

12 Cancer Tumor Profiling Market, Regional and Country Analysis

  • 12.1 Global Cancer Tumor Profiling Market, By Region, Historic and Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 12.2 Global Cancer Tumor Profiling Market, By Country, Historic and Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

13 Asia-Pacific Market

  • 13.1 Asia-Pacific Market Summary
    • 13.1.1 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 13.2 Asia-Pacific Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 13.3 Asia-Pacific Cancer Tumor Profiling Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 13.4 Asia-Pacific Cancer Tumor Profiling Market, Segmentation By Process Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 13.5 China Market
    • 13.5.1 China Market Summary
    • 13.5.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
    • 13.5.3 China Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 13.5.4 China Cancer Tumor Profiling Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 13.5.5 China Cancer Tumor Profiling Market, Segmentation By Process Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 13.6 India Market
    • 13.6.1 India Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 13.6.2 India Cancer Tumor Profiling Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 13.6.3 India Cancer Tumor Profiling Market, Segmentation By Process Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 13.7 Japan Market
    • 13.7.1 Japan Market Summary
    • 13.7.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
    • 13.7.3 Japan Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 13.7.4 Japan Cancer Tumor Profiling Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 13.7.5 Japan Cancer Tumor Profiling Market, Segmentation By Process Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 13.8 Australia Market
    • 13.8.1 Australia Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 13.8.2 Australia Cancer Tumor Profiling Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 13.8.3 Australia Cancer Tumor Profiling Market, Segmentation By Process Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 13.9 South Korea Market
    • 13.9.1 South Korea Market Summary
    • 13.9.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
    • 13.9.3 South Korea Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 13.9.4 South Korea Cancer Tumor Profiling Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 13.9.5 South Korea Cancer Tumor Profiling Market, Segmentation By Process Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 13.10 Taiwan Market
    • 13.10.1 Taiwan Market Summary
    • 13.10.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
    • 13.10.3 Taiwan Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 13.10.4 Taiwan Cancer Tumor Profiling Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 13.10.5 Taiwan Cancer Tumor Profiling Market, Segmentation By Process Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

14 South East Asia Market

  • 14.1 South East Asia Market Summary
  • 14.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
    • 14.2.1 South East Asia Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 14.2.2 South East Asia Cancer Tumor Profiling Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 14.2.3 South East Asia Cancer Tumor Profiling Market, Segmentation By Process Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 14.3 Indonesia Market
    • 14.3.1 Indonesia Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 14.3.2 Indonesia Cancer Tumor Profiling Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 14.3.3 Indonesia Cancer Tumor Profiling Market, Segmentation By Process Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

15 Western Europe Market

  • 15.1 Western Europe Market Summary
    • 15.1.1 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 15.2 Western Europe Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.3 Western Europe Cancer Tumor Profiling Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.4 Western Europe Cancer Tumor Profiling Market, Segmentation By Process Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.5 UK Market
    • 15.5.1 UK Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 15.5.2 UK Cancer Tumor Profiling Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 15.5.3 UK Cancer Tumor Profiling Market, Segmentation By Process Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.6 Germany Market
    • 15.6.1 Germany Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 15.6.2 Germany Cancer Tumor Profiling Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 15.6.3 Germany Cancer Tumor Profiling Market, Segmentation By Process Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.7 France Market
    • 15.7.1 France Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 15.7.2 France Cancer Tumor Profiling Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 15.7.3 France Cancer Tumor Profiling Market, Segmentation By Process Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.8 Italy Market
    • 15.8.1 Italy Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 15.8.2 Italy Cancer Tumor Profiling Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 15.8.3 Italy Cancer Tumor Profiling Market, Segmentation By Process Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.9 Spain Market
    • 15.9.1 Spain Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 15.9.2 Spain Cancer Tumor Profiling Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 15.9.3 Spain Cancer Tumor Profiling Market, Segmentation By Process Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

16 Eastern Europe Market

  • 16.1 Eastern Europe Market Summary
  • 16.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 16.3 Eastern Europe Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 16.4 Eastern Europe Cancer Tumor Profiling Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 16.5 Eastern Europe Cancer Tumor Profiling Market, Segmentation By Process Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 16.6 Russia Market
    • 16.6.1 Russia Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 16.6.2 Russia Cancer Tumor Profiling Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 16.6.3 Russia Cancer Tumor Profiling Market, Segmentation By Process Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

17 North America Market

  • 17.1 North America Market Summary
  • 17.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 17.3 North America Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.4 North America Cancer Tumor Profiling Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.5 North America Cancer Tumor Profiling Market, Segmentation By Process Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.6 USA Market
    • 17.6.1 USA Market Summary
    • 17.6.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
    • 17.6.3 USA Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 17.6.4 USA Cancer Tumor Profiling Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 17.6.5 USA Cancer Tumor Profiling Market, Segmentation By Process Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.7 Canada Market
    • 17.7.1 Canada Market Summary
    • 17.7.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
    • 17.7.3 Canada Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 17.7.4 Canada Cancer Tumor Profiling Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 17.7.5 Canada Cancer Tumor Profiling Market, Segmentation By Process Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

18 South America Market

  • 18.1 South America Market Summary
  • 18.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 18.3 South America Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.4 South America Cancer Tumor Profiling Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.5 South America Cancer Tumor Profiling Market, Segmentation By Process Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.6 Brazil Market
    • 18.6.1 Brazil Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 18.6.2 Brazil Cancer Tumor Profiling Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 18.6.3 Brazil Cancer Tumor Profiling Market, Segmentation By Process Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

19 Middle East Market

  • 19.1 Middle East Market Summary
  • 19.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 19.3 Middle East Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 19.4 Middle East Cancer Tumor Profiling Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 19.5 Middle East Cancer Tumor Profiling Market, Segmentation By Process Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

20 Africa Market

  • 20.1 Africa Market Summary
  • 20.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 20.3 Africa Cancer Tumor Profiling Market, Segmentation By Cancer Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 20.4 Africa Cancer Tumor Profiling Market, Segmentation By Technology, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 20.5 Africa Cancer Tumor Profiling Market, Segmentation By Process Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

21 Competitive Landscape And Company Profiles

  • 21.1 Cancer Tumor Profiling Market Competitive Landscape And & Market Share 2024
    • 21.1.1 Top 10 Companies (Ranked by revenue/share)
  • 21.2 Company Profiles
  • 21.3 Illumina Inc (Company Overview, Products and Services, Business Strategy, Financial Overview)
  • 21.4 Thermo Fisher Scientific Inc (Company Overview, Products and Services, Business Strategy, Financial Overview)
  • 21.5 F. Hoffmann-La Roche Ltd. (Foundation Medicine) (Company Overview, Products and Services, Business Strategy, Financial Overview)
  • 21.6 Caris Life Sciences Inc (Company Overview, Products and Services, Business Strategy, Financial Overview)
  • 21.7 Qiagen N.V. (Company Overview, Products and Services, Business Strategy, Financial Overview)

22 Other Major And Innovative Companies

  • 22.1 Tempus AI Inc.
  • 22.2 NeoGenomics Laboratories Inc.
  • 22.3 Exact Sciences Corporation
  • 22.4 Myriad Genetics Inc.
  • 22.5 Veracyte Inc.
  • 22.6 Bio-Rad Laboratories Inc.
  • 22.7 Sysmex Corporation
  • 22.8 Guardant Health Inc.
  • 22.9 Hologic Inc.
  • 22.10 Invitae Corporation
  • 22.11 Natera Inc.
  • 22.12 NantHealth Inc.
  • 22.13 RareCyte Inc.
  • 22.14 Personal Genome Diagnostics Inc.
  • 22.15 Strand Life Sciences Pvt. Ltd.

23 Competitive Benchmarking

24 Competitive Dashboard

25 Cancer Tumor Profiling Market - Company Scoring Matrix

  • 25.1 Innovation & Brand Leaders
  • 25.2 Emerging Innovators
  • 25.3 Brand-Driven Traditionalists
  • 25.4 Niche or Local Followers

26 Upcoming Startups In the Market

27 Key Mergers And Acquisitions

  • 27.1 Natera Acquired Foresight Diagnostics
  • 27.2 Quest Diagnostics Acquired Haystack Oncology

28 Recent Developments

  • 28.1 AI Insights Signature Launched For Breast Cancer Treatment Personalization
  • 28.2 Multiomic Tissue Profiling Test Launched For Precision Oncology

29 Opportunities And Strategies

  • 29.1 Global Cancer Tumor Profiling Market In 2030 - Countries Offering Most New Opportunities
  • 29.2 Global Cancer Tumor Profiling Market In 2030 - Segments Offering Most New Opportunities
  • 29.3 Global Cancer Tumor Profiling Market In 2030 - Growth Strategies
    • 29.3.1 Market Trend Based Strategies
    • 29.3.2 Competitor Strategies

30 Cancer Tumor Profiling Market, Conclusions And Recommendations

  • 30.1 Conclusions
  • 30.2 Recommendations
    • 30.2.1 Product
    • 30.2.2 Place
    • 30.2.3 Price
    • 30.2.4 Promotion
    • 30.2.5 People

31 Appendix

  • 31.1 Geographies Covered
  • 31.2 Market Data Sources
  • 31.3 Research Methodology
  • 31.4 Currencies
  • 31.5 The Business Research Company
  • 31.6 Copyright and Disclaimer